1. Home
  2. COGT vs DEC Comparison

COGT vs DEC Comparison

Compare COGT & DEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • DEC
  • Stock Information
  • Founded
  • COGT 2014
  • DEC 2001
  • Country
  • COGT United States
  • DEC United States
  • Employees
  • COGT N/A
  • DEC N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • DEC
  • Sector
  • COGT Health Care
  • DEC
  • Exchange
  • COGT Nasdaq
  • DEC Nasdaq
  • Market Cap
  • COGT 1.1B
  • DEC 1.2B
  • IPO Year
  • COGT 2018
  • DEC N/A
  • Fundamental
  • Price
  • COGT $16.19
  • DEC $13.42
  • Analyst Decision
  • COGT Strong Buy
  • DEC Strong Buy
  • Analyst Count
  • COGT 11
  • DEC 4
  • Target Price
  • COGT $21.20
  • DEC $22.25
  • AVG Volume (30 Days)
  • COGT 1.9M
  • DEC 645.6K
  • Earning Date
  • COGT 11-11-2025
  • DEC 01-01-0001
  • Dividend Yield
  • COGT N/A
  • DEC 6.07%
  • EPS Growth
  • COGT N/A
  • DEC N/A
  • EPS
  • COGT N/A
  • DEC N/A
  • Revenue
  • COGT N/A
  • DEC $1,148,432,000.00
  • Revenue This Year
  • COGT N/A
  • DEC $128.26
  • Revenue Next Year
  • COGT N/A
  • DEC N/A
  • P/E Ratio
  • COGT N/A
  • DEC N/A
  • Revenue Growth
  • COGT N/A
  • DEC 64.19
  • 52 Week Low
  • COGT $3.72
  • DEC $10.08
  • 52 Week High
  • COGT $16.46
  • DEC $17.70
  • Technical
  • Relative Strength Index (RSI)
  • COGT 74.84
  • DEC 36.18
  • Support Level
  • COGT $15.26
  • DEC $13.18
  • Resistance Level
  • COGT $16.22
  • DEC $14.12
  • Average True Range (ATR)
  • COGT 0.71
  • DEC 0.33
  • MACD
  • COGT 0.21
  • DEC -0.04
  • Stochastic Oscillator
  • COGT 92.27
  • DEC 22.30

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About DEC Diversified Energy Company plc

Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.

Share on Social Networks: